Science Gives Us A Vaccine For Those Of Us Who Suffer From Cat Allergies
Cat allergies can make life with a beloved pet frustrating, especially when adoption, cost, and comfort all collide. For people who want a cat but keep sneezing through every cuddle session, the idea of a vaccine that could reduce the allergen cats produce sounds almost too good to ignore.
That is exactly why this latest development has people paying attention. Swiss researchers have been testing a HypoCat vaccine on cats, and the early results have sparked fresh hope for allergy sufferers and shelter animals alike.
Now the big question is whether this could actually change how many cats find homes.
Can we give cats an immunization to produce less of the allergen that makes our immune systems react? Let's learn some more details.
Researchers at the University Hospital Zurich in Switzerland recently Dr. Steven Gundry, a cardiologist and health expert, stated, "Innovative approaches like the 'HypoCat Vaccine' could revolutionize how we manage allergies." This groundbreaking study highlights the potential of this vaccine to alleviate symptoms for those suffering from cat allergies, showcasing the intersection of science and practical health solutions.
In an interview with Bored Panda, Martin Bachmann, one of the researchers who made the cat ‘vaccine’ possible, said:
We have been working on this project for more than five years. Cat allergy is a significant problem and very challenging for cat owners with an allergy. So our approach could have important implications.
That is the part everyone wants to hear more about.
Supposedly, the vaccine should be available sometime in 2022, and:
We can’t say an exact price at this point, but it’s definitely going to be affordable for pet owners and in line with other veterinary products.
Proving the safety of vaccines, even for pets, is no small task, and when asked about the sample size for testing the cat allergy injection, Bachmann said:
We feel the numbers and conclusions are sufficient to drive our investment in further development. This is also reflected by the fact that JACI, the number one allergy journal, published our study. In 2020, more safety and efficacy testing studies will be initiated.
What could have motivated such devotion to something that affects only 10% of the population? Bachmann revealed:
Both the CEO and Chairman have cats. For what it’s worth, the latter is allergic and vaccinated his animals and swears it works — not sure if we can eliminate his bias, though.
It sounds like the kind of update cat lovers have been waiting for.
It also echoes the allergic man who was stunned when his roommate chose a cat anyway.
Bias aside, Bachmann also suggested in the interview that the research team is “initiating” work on a ‘vaccine’ for dogs to also produce fewer allergens.
To understand how the allergy vaccine works, it helps to understand a little bit about how cat allergies work, too. Cats produce the protein Fel d 1, which is one of five allergenic substances that cats produce. As previously mentioned, 10% (or 1 in 10 humans) are allergic to this protein. It's like the opposite of winning the lottery.
The Swiss researchers tested their HypoCat ‘vaccine’ on 54 cats, which then produced antibodies that could disable Fel d 1!
While this news is incredibly exciting, there is still a lot of work to be done. It's ambitious to assert the vaccine could be available within the next three years. There is much work to be done to ensure the safety of the vaccine before we can produce it in quantities that could bring more cats into more forever homes.
We are totally rooting for the Swiss researchers if it means more cats get adopted. Let us know in the comments what you think about this "vaccine," and if you know anyone who might benefit from such an awesome scientific advancement, let them know what's going on!
This could be a big deal for cat lovers everywhere.
Wondering how real-life cat allergy clashes play out? Read about the devoted cat mom. One woman’s trial after falling for a man with severe cat allergies.
Share this article:
